Influence of healthy lifestyle habits on chronic disorders

J&J’s asset works by delivering an actinium-based radioligand which emits high-energy short-range alpha particles. Image credit: Shutterstock/Jurik Peter. Johnson & Johnson’s (J&J) prostate cancer radiotherapy

The orphan drug designation programme is an FDA initiative to support the development of new treatments for rare diseases. Credit: Kateryna Kon via Shutterstock. The

Iterum Therapeutics’s urinary tract infection antibiotic, oral sulopenem, is facing an FDA approval decision ahead of its 25 October PDUFA date. Credit: boonchai wedmakawand via